Pernix Ireland Pain DAC US$45M Loan Note Program


3 Burlington Road,
Dublin
Ireland, D04 RD68
Listed Since: 2017/10/11
Delisted on: 2021/04/30
Tel: 1-800-793-2145
Email: Gordon.Cox@estera.com

Pernix Ireland Pain Designated Activity Company (the “Issuer”) is a designated activity company limited by shares incorporated on 19 March 2015 under the laws of Ireland (registration number 559207). The Issuer is a direct and wholly owned subsidiary of Pernix Therapeutics Holdings, Inc. (organizational identification number D04539888), having its registered office at 10 North Park Place, Suite 201, Morristown, NJ 07960, United States. The Issuer’s registered office is located at 3 Burlington Road, Dublin 4, Ireland and its telephone number is 1-800-793-2145.

FINANCIAL AND OTHER INFORMATION

Title Description Date Posted
2016 Financials Pernix Ireland Pain Designated Activity Company 2016 Financials Pernix Ireland Pain Designated Activity Company 2018/06/07
2017 Financials Pernix Therapeutics Holdings Inc 2017 Financials Pernix Therapeutics Holdings Inc 2018/03/13
2016 Financials Pernix Therapeutics Holdings Inc 2016 Financials Pernix Therapeutics Holdings Inc 2017/10/11

DIRECTORY

Name Position Email
Mr. Ken Piña Director
Mr. Angus Smith Director
Mr. John Sedor Director

LISTING SPONSOR

Company Name Street Address
Ocorian Securities (Bermuda) Limited Ocorian Securities (Bermuda) Limited Victoria Place 5th Floor 31 Victoria Street Hamilton, HM 10 Bermuda
MIAX Logo
TRADING HOURSLOCATION
 
08:30-09:00 Price Discovery Exchange House
09:00-16:30 Continuous Trading 110 Pitts Bay Road
  Pembroke, Bermuda
   
CONTACT DETAILSMAILING ADDRESS
 
TEL: +1 (441) 292 7212 P.O. Box HM 1369
FAX: +1 (441) 292 7619 Hamilton HMFX
Contact Us (info@bsx.com)  
DISCLAIMER
 
The information contained in these pages has been obtained from sources which The Bermuda Stock Exchange believes are reliable. However, the accuracy of the information cannot and is not guaranteed and The Bermuda Stock Exchange makes no representation as to its accuracy or completeness. Neither this Web site, nor any information contained herein, constitutes advice or a solicitation to subscribe, purchase or sell any securities. The Bermuda Stock Exchange expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon any part of the contents of this site or any external sites referenced from this website.